AiDAPT: automated insulin delivery amongst pregnant women with type 1 diabetes: a multicentre randomized controlled trial – study protocol

Abstract Background Pregnant women with type 1 diabetes strive for tight glucose targets (3.5-7.8 mmol/L) to minimise the risks of obstetric and neonatal complications. Despite using diabetes technologies including continuous glucose monitoring (CGM), insulin pumps and contemporary insulin analogues...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Tara T. M. Lee, Corinne Collett, Mei-See Man, Matt Hammond, Lee Shepstone, Sara Hartnell, Eleanor Gurnell, Caroline Byrne, Eleanor M. Scott, Robert S. Lindsay, Damian Morris, Anna Brackenridge, Anna R. Dover, Rebecca M. Reynolds, Katharine F. Hunt, David R. McCance, Katharine Barnard-Kelly, David Rankin, Julia Lawton, Laura E. Bocchino, Judy Sibayan, Craig Kollman, Malgorzata E. Wilinska, Roman Hovorka, Helen R. Murphy, on behalf of the AiDAPT Collaborative Group
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2022-04-01
coleção:	BMC Pregnancy and Childbirth
Acesso em linha:	https://doi.org/10.1186/s12884-022-04543-z
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!